Related Experiment Video
Updated: Jun 12, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Ebola and marburg hemorrhagic fever
Amy L Hartman1, Jonathan S Towner, Stuart T Nichol
1University of Pittsburgh, Center for Vaccine Research, PA 15261, USA. hartman2@pitt.edu <hartman2@pitt.edu>
Abstract:
Ebola and Marburg viruses cause a severe viral hemorrhagic fever disease mainly in Sub-Saharan Africa. Although outbreaks are sporadic, there is the potential for filoviruses to spread to other continents unintentionally because of air travel or intentionally because of bioterrorism. This article discusses the natural history, epidemiology, and clinical presentation of patients infected with Ebola and Marburg viruses. Clinicians in the United States should be aware of the symptoms of these viral infections in humans and know the appropriate procedures for contacting local, state, and national reference laboratories in the event of a suspected case of filoviral hemorrhagic fever.
Related Concept Videos
Yellow Fever
Arboviral Encephalitis
Cross-reactivity
Hemorrhagic Stroke ll: Pathophysiology
Coronavirus
Viral Hepatitis I: Introduction

